{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:09:33Z","timestamp":1791572973294,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004048","name":"Kashan University of Medical Sciences","doi-asserted-by":"publisher","award":["3150"],"award-info":[{"award-number":["3150"]}],"id":[{"id":"10.13039\/501100004048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004048","name":"Kashan University of Medical Sciences","doi-asserted-by":"publisher","award":["3150"],"award-info":[{"award-number":["3150"]}],"id":[{"id":"10.13039\/501100004048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Carbapenem-resistant\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (CRKP) is a significant clinical problem, given the lack of therapeutic options. The CRKP strains have emerged as an essential worldwide healthcare issue during the last 10\u00a0years. Global expansion of the CRKP has made it a significant public health hazard. We must consider to novel therapeutic techniques. Bacteriophages are potent restorative cases against infections with multiple drug-resistant bacteria. The Phages offer promising prospects for the treatment of CRKP infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      In this study, a novel\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      phage vB_KshKPC-M was isolated, characterized, and sequenced, which was able to infect and lyse Carbapenem-resistant\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      host specifically.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      One hundred clinical isolates of\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      were collected from patients with COVID-19 associated with ventilator-associated acute pneumonia hospitalized at Shahid Beheshti Hospital, Kashan, Iran, from 2020 to 2021. Initially, all samples were cultured, and bacterial isolates identified by conventional biochemical tests, and then the\n                      <jats:italic>ureD<\/jats:italic>\n                      gene was used by PCR to confirm the isolates. The Antibiotic susceptibility test in the disc diffusion method and Minimum inhibitory concentrations for Colistin was done and interpreted according to guidelines. Phenotypic and molecular methods determined the Carbapenem resistance of isolates. The\n                      <jats:italic>blaKPC<\/jats:italic>\n                      ,\n                      <jats:italic>blaNDM<\/jats:italic>\n                      , and\n                      <jats:italic>blaOXA-23<\/jats:italic>\n                      genes were amplified for this detection. Biofilm determination of CRKP isolates was performed using a quantitative microtiter plate (MTP) method. The phage was isolated from wastewater during the summer season at a specific position from Beheshti Hospital (Kashan, Iran). The sample was processed and purified against the bacterial host, a CRKP strain isolated from a patient suffering from COVID-19 pneumoniae and resistance to Colistin with high potency for biofilm production. This isolate is called Kp100. The separated phages were diluted and titration by the double overlay agar plaque assay. The separate Phage is concentrated with 10% PEG and stored at \u221280\u00a0\u00b0C until use. The phage host range was identified by the spot test method. The purified phage morphology was determined using a transmission electron microscope. The phage stability tests (pH and temperature) were analyzed. The effect of cationic ions on phage adsorption was evaluated. The optimal titer of bacteriophage was determined to reduce the concentration of the CRKP strain. One-step growth assays were performed to identify the purified phage burst\u2019s latent cycle and size. The SDS-PAGE was used for phage proteins analysis. Phage DNA was extracted by chloroform technique, and the whole genome of lytic phage was sequenced using Illumina HiSeq technology (Illumina, San Diego, CA). For quality assurance and preprocessing, such as trimming, Geneious Prime 2021.2.2 and Spades 3.9.0. The whole genome sequence of the lytic phage is linked to the GenBank database accession number. RASTtk\u2014v1.073 was used to predict and annotate the ORFs. Prediction of ORF was performed using PHASTER software. ResFinder is used to assess the presence of antimicrobial resistance and virulence genes in the genome. The tRNAs can-SE v2.0.6 is used to determine the presence of tRNA in the genome. Linear genome comparisons of phages and visualization of coding regions were performed using Easyfig 2.2.3 and Mauve 2.4.0. Phage lifestyles were predicted using the program PHACTS. Phylogenetic analysis and amino acid sequences of phage core proteins, such as the major capsid protein. Phylogenies were reconstructed using the Neighbor-Joining method with 1000 bootstrap repeat. HHpred software was used to predict depolymerase. In this study, GraphPad Prism version 9.1 was used for the statistical analysis. Student\u2019s t-test was used to compare the sets and the control sets, and the significance level was set at P\u2009\u2264\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Phage vB_KshKPC-M is assigned to the\n                      <jats:italic>Siphoviridae<\/jats:italic>\n                      , order\n                      <jats:italic>Caudovirales<\/jats:italic>\n                      . It was identified as a linear double-stranded DNA phage of 54,378\u00a0bp with 50.08% G\u2009+\u2009C content, had a relatively broad host range (97.7%), a short latency of 20\u00a0min, and a high burst size of 260 PFU\/cell, and was maintained stable at different pH (3\u201311) and temperature (45\u201365\u00a0\u00b0C). The vB_KshKPC-M genome contains 91 open-reading frames. No tRNA, antibiotic resistance, toxin, virulence-related genes, or lysogen-forming gene clusters were detected in the phage genome.\n                    <\/jats:p>\n                    <jats:p>\n                      Comparative genomic analysis revealed that phage vB_KshKPC-M has sequence similarity to the\n                      <jats:italic>Klebsiella<\/jats:italic>\n                      phages, phage 13 (NC_049844.1), phage Sushi (NC_028774.1), phage vB_KpnD_PeteCarol (OL539448.1) and phage PWKp14 (MZ634345.1).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The broad host range and antibacterial activity make it a promising candidate for future phage therapy applications. The isolated phage was able to lyse most of the antibiotic-resistant clinical isolates. Therefore, this phage can be used alone or as a phage mixture in future studies to control and inhibit respiratory infections caused by these bacteria, especially in treating respiratory infections caused by resistant strains in sick patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-023-00567-1","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T11:02:57Z","timestamp":1677236577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Mehrdad","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Saffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hossein","family":"Hejazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shayestehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Motallebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Eidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"issue":"1","key":"567_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-019-0343-8","volume":"19","author":"CY Effah","year":"2020","unstructured":"Effah CY, Sun T, Liu S, Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020;19(1):1.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"567_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","volume":"80","author":"MK Paczosa","year":"2016","unstructured":"Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"567_CR3","doi-asserted-by":"publisher","first-page":"e00001","DOI":"10.1128\/CMR.00001-19","volume":"32","author":"TA Russo","year":"2019","unstructured":"Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019;32(3):e00001-00019.","journal-title":"Clin Microbiol Rev"},{"key":"567_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00181-19","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/CMR.00181-19.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"567_CR5","doi-asserted-by":"publisher","first-page":"105833","DOI":"10.1016\/j.ijantimicag.2019.10.014","volume":"55","author":"AA Agyeman","year":"2020","unstructured":"Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents. 2020;55(1):105833.","journal-title":"Int J Antimicrob Agents"},{"key":"567_CR6","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41564-019-0492-8","volume":"4","author":"S David","year":"2019","unstructured":"David S, Reuter S, Harris S, Glasner C, Feltwell T, Argimon S, Abudahab K, Goater R, Giani T, Errico G. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol. 2019;4:1919\u201329.","journal-title":"Nat Microbiol"},{"issue":"10342","key":"567_CR7","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/S0140-6736(22)01011-X","volume":"399","author":"S Shen","year":"2022","unstructured":"Shen S, Shi Q, Hu F. The changing face of <em>Klebsiella pneumoniae<\/em> carbapenemase: in-vivo mutation in patient with chest infection. The Lancet. 2022;399(10342):2226.","journal-title":"The Lancet"},{"issue":"3","key":"567_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1556\/1886.2020.00022","volume":"10","author":"GB Rasmus","year":"2020","unstructured":"Rasmus GB, Soraya M, Stefan B, Markus MH. Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae. Eur J Microbiol Immunol. 2020;10(3):115\u201324.","journal-title":"Eur J Microbiol Immunol"},{"issue":"8","key":"567_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/1120009X.2022.2064698","volume":"34","author":"P Ergen","year":"2022","unstructured":"Ergen P, Ko\u00e7o\u011flu ME, Nural M, Ku\u015fkucu MA, Aydin \u00d6, \u0130nal FY, \u00d6zt\u00fcrk H, \u00dc\u00e7i\u015fik AC, \u00c7a\u015fkurlu H, G\u00fcneysu B, et al. Carbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study. J Chemother. 2022;34(8):517\u201323.","journal-title":"J Chemother"},{"key":"567_CR10","doi-asserted-by":"publisher","first-page":"e936498","DOI":"10.12659\/AJCR.936498","volume":"23","author":"BJ Pazmi\u00f1o G\u00f3mez","year":"2022","unstructured":"Pazmi\u00f1o G\u00f3mez BJ, Rodas Pazmi\u00f1o JP, Gonz\u00e1lez Quinde GS, Guevara Viej\u00f3 JF, Merejildo Amagua\u00f1a MJ, Rodas Neira \u00c9I, Rizzo Rodr\u00edguez FA, Cagua Monta\u00f1o LE, Rodas Pazmi\u00f1o KA. Multidrug-resistant Klebsiella pneumoniae in a patient with SARS-Cov-2 pneumonia in an intensive care unit in Guayaquil, Ecuador: a case report. Am J Case Rep. 2022;23:e936498.","journal-title":"Am J Case Rep"},{"issue":"01","key":"567_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cjtee.2021.11.001","volume":"25","author":"M Wu","year":"2022","unstructured":"Wu M, Zou Z-Y, Chen Y-H, Wang C-L, Feng Y-W, Liu Z-F. Severe COVID-19-associated sepsis is different from classical sepsis induced by pulmonary infection with carbapenem-resistant Klebsiella pneumonia (CrKP). Chin J Traumatol. 2022;25(01):17\u201324.","journal-title":"Chin J Traumatol"},{"issue":"5","key":"567_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/antibiotics10050561","volume":"10","author":"IM Dumitru","year":"2021","unstructured":"Dumitru IM, Dumitrascu M, Vlad ND, Cernat RC, Ilie-Serban C, Hangan A, Slujitoru RE, Gherghina A, Mitroi-Maxim C, Curtali L, et al. Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19. Antibiotics. 2021;10(5):561.","journal-title":"Antibiotics"},{"key":"567_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.638094","author":"N Wu","year":"2021","unstructured":"Wu N, Zhu T. Potential of therapeutic bacteriophages in nosocomial infection management. Front Microbiol. 2021. https:\/\/doi.org\/10.3389\/fmicb.2021.638094.","journal-title":"Front Microbiol"},{"issue":"1","key":"567_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/v13010051","volume":"13","author":"RK Al-Ishaq","year":"2021","unstructured":"Al-Ishaq RK, Skariah S, B\u00fcsselberg D. Bacteriophage treatment: critical evaluation of its application on World Health Organization priority pathogens. Viruses. 2021;13(1):51.","journal-title":"Viruses"},{"issue":"4","key":"567_CR15","doi-asserted-by":"publisher","first-page":"e00012","DOI":"10.1128\/MMBR.00012-19","volume":"83","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska K, Abedon ST. Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies. Microbiol Mol Biol Rev. 2019;83(4):e00012-00019.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"567_CR16","doi-asserted-by":"publisher","first-page":"e2041","DOI":"10.1002\/rmv.2041","volume":"29","author":"S Rehman","year":"2019","unstructured":"Rehman S, Ali Z, Khan M, Bostan N, Naseem S. The dawn of phage therapy. Rev Med Virol. 2019;29(4):e2041.","journal-title":"Rev Med Virol"},{"issue":"11","key":"567_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9110827","volume":"9","author":"A G\u00f3rski","year":"2020","unstructured":"G\u00f3rski A, Borysowski J, Mi\u0119dzybrodzki R. Phage therapy: towards a successful clinical trial. Antibiotics. 2020;9(11):1\u20137.","journal-title":"Antibiotics"},{"issue":"12","key":"567_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11908-020-00742-x","volume":"22","author":"N Law","year":"2020","unstructured":"Law N, Aslam S. phage therapy: primer and role in the treatment of MDROs. Curr Infect Dis Rep. 2020;22(12):31.","journal-title":"Curr Infect Dis Rep"},{"issue":"1","key":"567_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/ph14010034","volume":"14","author":"N D\u00fczg\u00fcne\u015f","year":"2021","unstructured":"D\u00fczg\u00fcne\u015f N, Sessevmez M, Yildirim M. Bacteriophage therapy of bacterial infections: the rediscovered frontier. Pharmaceuticals. 2021;14(1):34.","journal-title":"Pharmaceuticals"},{"issue":"4","key":"567_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/03009734.2019.1688433","volume":"124","author":"AS Nilsson","year":"2019","unstructured":"Nilsson AS. Pharmacological limitations of phage therapy. Ups J Med Sci. 2019;124(4):218\u201327.","journal-title":"Ups J Med Sci"},{"issue":"1","key":"567_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/ph12010035","volume":"12","author":"P Hyman","year":"2019","unstructured":"Hyman P. Phages for phage therapy: isolation, characterization, and host range breadth. Pharmaceuticals. 2019;12(1):35.","journal-title":"Pharmaceuticals"},{"key":"567_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fphar.2019.00513","volume":"10","author":"N Principi","year":"2019","unstructured":"Principi N, Silvestri E, Esposito S. Advantages and limitations of bacteriophages for the treatment of bacterial infections. Front Pharmacol. 2019;10:513.","journal-title":"Front Pharmacol"},{"issue":"4","key":"567_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/v11040343","volume":"11","author":"S McCallin","year":"2019","unstructured":"McCallin S, Sacher JC, Zheng J, Chan BK. Current state of compassionate phage therapy. Viruses. 2019;11(4):343.","journal-title":"Viruses"},{"key":"567_CR24","doi-asserted-by":"publisher","first-page":"2347872","DOI":"10.1155\/2021\/2347872","volume":"2021","author":"A Ghanizadeh","year":"2021","unstructured":"Ghanizadeh A, Najafizade M, Rashki S, Marzhoseyni Z, Motallebi M. Genetic diversity, antimicrobial resistance pattern, and biofilm formation in <i>Klebsiella pneumoniae<\/i> isolated from patients with coronavirus disease 2019 (COVID-19) and ventilator-associated pneumonia. Biomed Res Int. 2021;2021:2347872.","journal-title":"Biomed Res Int"},{"key":"567_CR25","unstructured":"CLSI C: Performance standards for antimicrobial susceptibility testing. Clinical Lab Standards Institute 2021."},{"key":"567_CR26","doi-asserted-by":"publisher","first-page":"561741","DOI":"10.3389\/fcimb.2020.561741","volume":"10","author":"EG Di Domenico","year":"2020","unstructured":"Di Domenico EG, Cavallo I, Sivori F, Marchesi F, Prignano G, Pimpinelli F, Sperduti I, Pelagalli L, Di Salvo F, Celesti I, et al. Biofilm production by carbapenem-resistant Klebsiella pneumoniae significantly increases the risk of death in oncological patients. Front Cell Infect Microbiol. 2020;10:561741.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"567_CR27","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.03786-14","volume":"59","author":"SM Lehman","year":"2015","unstructured":"Lehman SM, Donlan RM. Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model. Antimicrob Agents Chemother. 2015;59(2):1127\u201337.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"567_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/0892701021000034418","volume":"18","author":"K Tait","year":"2002","unstructured":"Tait K, Skillman LC, Sutherland IW. The efficacy of bacteriophage as a method of biofilm eradication. Biofouling. 2002;18(4):305\u201311.","journal-title":"Biofouling"},{"key":"567_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0467-9","volume-title":"Microbial biofilms: methods and protocols","author":"G Donelli","year":"2014","unstructured":"Donelli G. Microbial biofilms: methods and protocols. Berlin: Springer; 2014."},{"key":"567_CR30","first-page":"1","volume-title":"Bacteriophages: biology, technology, therapy","author":"F van Charante","year":"2019","unstructured":"van Charante F, Holtappels D, Blasdel B, Burrowes B. Isolation of bacteriophages. In: Harper DR, Abedon ST, Burrowes BH, McConville ML, editors. Bacteriophages: biology, technology, therapy. Cham: Springer International Publishing; 2019. p. 1\u201332."},{"key":"567_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/978-3-319-41986-2_16","volume-title":"Bacteriophages: biology, technology, therapy","author":"ST Abedon","year":"2021","unstructured":"Abedon ST. Detection of bacteriophages: phage plaques. In: Harper DR, Abedon ST, Burrowes BH, McConville ML, editors. Bacteriophages: biology, technology, therapy. Cham: Springer International Publishing; 2021. p. 507\u201338."},{"issue":"5","key":"567_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","volume":"8","author":"SJ Labrie","year":"2010","unstructured":"Labrie SJ, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol. 2010;8(5):317\u201327.","journal-title":"Nat Rev Microbiol"},{"key":"567_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-1-4939-7395-8_17","volume-title":"Bacteriophage therapy: from lab to clinical practice","author":"MB \u0141obocka","year":"2018","unstructured":"\u0141obocka MB, G\u0142owacka A, Golec P. Methods for bacteriophage preservation. In: Azeredo J, Sillankorva S, editors. Bacteriophage therapy: from lab to clinical practice. New York, NY: Springer, New York; 2018. p. 219\u201330."},{"issue":"7","key":"567_CR34","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/v14071490","volume":"14","author":"T Glonti","year":"2022","unstructured":"Glonti T, Pirnay J-P. In vitro techniques and measurements of phage characteristics that are important for phage therapy success. Viruses. 2022;14(7):1490.","journal-title":"Viruses"},{"key":"567_CR35","first-page":"1","volume-title":"Bacteriophages: biology, technology, therapy","author":"DM Belnap","year":"2020","unstructured":"Belnap DM. Detection of bacteriophages: electron microscopy and visualisation. In: Harper DR, Abedon ST, Burrowes BH, McConville ML, editors. Bacteriophages: biology, technology, therapy. Cham: Springer International Publishing; 2020. p. 1\u201361."},{"key":"567_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-26736-0","volume-title":"Phage therapy: a practical approach","author":"A G\u00f3rski","year":"2019","unstructured":"G\u00f3rski A, Mi\u0119dzybrodzki R, Borysowski J. Phage therapy: a practical approach. Berlin: Springer; 2019."},{"key":"567_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8940-9","volume-title":"Bacteriophages, vol. IV","author":"MR Clokie","year":"2019","unstructured":"Clokie MR, Kropinski AM, Lavigne R. Bacteriophages, vol. IV. Berlin: Springer; 2019."},{"issue":"5","key":"567_CR38","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41587-020-00774-7","volume":"39","author":"S Nayfach","year":"2021","unstructured":"Nayfach S, Camargo AP, Schulz F, Eloe-Fadrosh E, Roux S, Kyrpides NC. CheckV assesses the quality and completeness of metagenome-assembled viral genomes. Nat Biotechnol. 2021;39(5):578\u201385.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"567_CR39","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.1038\/srep08365","volume":"5","author":"T Brettin","year":"2015","unstructured":"Brettin T, Davis JJ, Disz T, Edwards RA, Gerdes S, Olsen GJ, Olson R, Overbeek R, Parrello B, Pusch GD, et al. RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci Rep. 2015;5(1):8365.","journal-title":"Sci Rep"},{"key":"567_CR40","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000748","author":"AF Florensa","year":"2022","unstructured":"Florensa AF, Kaas RS, Clausen PTLC, Aytan-Aktug D, Aarestrup FM. ResFinder\u2014an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes. Microb Genom. 2022. https:\/\/doi.org\/10.1099\/mgen.0.000748.","journal-title":"Microb Genom"},{"issue":"16","key":"567_CR41","doi-asserted-by":"publisher","first-page":"9077","DOI":"10.1093\/nar\/gkab688","volume":"49","author":"P Chan Patricia","year":"2021","unstructured":"Chan Patricia P, Lin Brian Y, Mak Allysia J, Lowe TM. tRNAscan-SE 2.0: improved detection and functional classification of transfer RNA genes. Nucleic Acids Res. 2021;49(16):9077\u201396.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"567_CR42","first-page":"1009","volume":"27","author":"MJ Sullivan","year":"2011","unstructured":"Sullivan MJ, Petty NK, Beatson SA. Easyfig: a genome comparison visualizer. Bioinformatics (Oxford, England). 2011;27(7):1009\u201310.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"7","key":"567_CR43","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1101\/gr.2289704","volume":"14","author":"AC Darling","year":"2004","unstructured":"Darling AC, Mau B, Blattner FR, Perna NT. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 2004;14(7):1394\u2013403.","journal-title":"Genome Res"},{"issue":"5","key":"567_CR44","first-page":"614","volume":"28","author":"K McNair","year":"2012","unstructured":"McNair K, Bailey BA, Edwards RA. PHACTS, a computational approach to classifying the lifestyle of phages. Bioinformatics (Oxford, England). 2012;28(5):614\u20138.","journal-title":"Bioinformatics (Oxford, England)"},{"key":"567_CR45","first-page":"299","volume-title":"Colony PCR methods. In enzymology. Vol. 529","author":"M Bergkessel","year":"2013","unstructured":"Bergkessel M, Guthrie C. Colony PCR methods. In enzymology. Vol. 529. Amsterdam: Elsevier; 2013. p. 299\u2013309."},{"issue":"7","key":"567_CR46","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38(7):3022\u20137.","journal-title":"Mol Biol Evol"},{"key":"567_CR47","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gki408","volume":"33","author":"J S\u00f6ding","year":"2005","unstructured":"S\u00f6ding J, Biegert A, Lupas AN. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res. 2005;33:W244\u20138.","journal-title":"Nucleic Acids Res"},{"key":"567_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/v4040471","volume":"4","author":"A Chibeu","year":"2012","unstructured":"Chibeu A, Lingohr EJ, Masson L, Manges A, Harel J, Ackermann H-W, Kropinski AM, Boerlin P. Bacteriophages with the ability to degrade uropathogenic escherichia coli biofilms. Viruses. 2012;4:471\u201387.","journal-title":"Viruses"},{"issue":"2","key":"567_CR49","doi-asserted-by":"publisher","first-page":"e0008022","DOI":"10.1128\/msphere.00080-22","volume":"7","author":"Q Fang","year":"2022","unstructured":"Fang Q, Zong Z. Lytic phages against ST11 K47 carbapenem-resistant Klebsiella pneumoniae and the corresponding phage resistance mechanisms. mSphere. 2022;7(2):e0008022.","journal-title":"mSphere"},{"issue":"5","key":"567_CR50","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11262-021-01847-8","volume":"57","author":"M Li","year":"2021","unstructured":"Li M, Li P, Chen L, Guo G, Xiao Y, Chen L, Du H, Zhang W. Identification of a phage-derived depolymerase specific for KL64 capsule of Klebsiella pneumoniae and its anti-biofilm effect. Virus Genes. 2021;57(5):434\u201342.","journal-title":"Virus Genes"},{"key":"567_CR51","doi-asserted-by":"publisher","first-page":"198506","DOI":"10.1016\/j.virusres.2021.198506","volume":"303","author":"J Feng","year":"2021","unstructured":"Feng J, Gao L, Li L, Zhang Z, Wu C, Li F, Tong Y. Characterization and genome analysis of novel Klebsiella phage BUCT556A with lytic activity against carbapenemase-producing Klebsiella pneumoniae. Virus Res. 2021;303:198506.","journal-title":"Virus Res"},{"key":"567_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00218","author":"Y Liu","year":"2020","unstructured":"Liu Y, Leung SSY, Huang Y, Guo Y, Jiang N, Li P, Chen J, Wang R, Bai C, Mi Z, et al. Identification of two depolymerases from phage IME205 and their antivirulent functions on K47 capsule of Klebsiella pneumoniae. Front Microbiol. 2020. https:\/\/doi.org\/10.3389\/fmicb.2020.00218.","journal-title":"Front Microbiol"},{"issue":"1","key":"567_CR53","first-page":"97","volume":"165","author":"Y Shi","year":"2020","unstructured":"Shi Y, Chen Y, Yang Z, Zhang Y, You B, Liu X, Chen P, Liu M, Zhang C, Luo X, et al. Characterization and genome sequencing of a novel T7-like lytic phage, kpssk3, infecting carbapenem-resistant Klebsiella pneumoniae. Adv Virol. 2020;165(1):97\u2013104.","journal-title":"Adv Virol"},{"key":"567_CR54","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3389\/fmicb.2020.01554","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Guo M, Chen L, Zhu C, Xiao Y, Li P, Guo H, Chen L, Zhang W, Du H. Isolation and characterization of novel lytic bacteriophages infecting epidemic carbapenem-resistant Klebsiella pneumoniae strains. Front Microbiol. 2020;11:1554.","journal-title":"Front Microbiol"},{"issue":"1","key":"567_CR55","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/med.21593","volume":"40","author":"A G\u00f3rski","year":"2020","unstructured":"G\u00f3rski A, Mi\u0119dzybrodzki R, W\u0119grzyn G, Jo\u0144czyk-Matysiak E, Borysowski J, Weber-D\u0105browska B. Phage therapy: current status and perspectives. Med Res Rev. 2020;40(1):459\u201363.","journal-title":"Med Res Rev"},{"issue":"7","key":"567_CR56","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/v13071268","volume":"13","author":"D Liu","year":"2021","unstructured":"Liu D, Van Belleghem JD, de Vries CR, Burgener E, Chen Q, Manasherob R, Aronson JR, Amanatullah DF, Tamma PD, Suh GA. The safety and toxicity of phage therapy: a review of animal and clinical studies. Viruses. 2021;13(7):1268.","journal-title":"Viruses"},{"key":"567_CR57","doi-asserted-by":"publisher","first-page":"198348","DOI":"10.1016\/j.virusres.2021.198348","volume":"297","author":"C Zhang","year":"2021","unstructured":"Zhang C, Yuan J, Guo C, Ge C, Wang X, Wei D, Li X, Si H, Hu C. Identification and complete genome of lytic \u201cKp34likevirus\u201d phage vB_KpnP_Bp5 and therapeutic potency in the treatment of lethal Klebsiella pneumoniae infections in mice. Virus Res. 2021;297:198348.","journal-title":"Virus Res"},{"issue":"1","key":"567_CR58","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1038\/s41598-020-62691-8","volume":"10","author":"M Horv\u00e1th","year":"2020","unstructured":"Horv\u00e1th M, Kov\u00e1cs T, Koderivalappil S, \u00c1brah\u00e1m H, R\u00e1khely G, Schneider G. Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates. Sci Rep. 2020;10(1):5891.","journal-title":"Sci Rep"},{"issue":"5","key":"567_CR59","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00284-019-01849-8","volume":"77","author":"M Gao","year":"2020","unstructured":"Gao M, Wang C, Qiang X, Liu H, Li P, Pei G, Zhang X, Mi Z, Huang Y, Tong Y, et al. Isolation and characterization of a novel bacteriophage infecting carbapenem-resistant Klebsiella pneumoniae. Curr Microbiol. 2020;77(5):722\u20139.","journal-title":"Curr Microbiol"},{"issue":"9","key":"567_CR60","first-page":"2389","volume":"164","author":"T Teng","year":"2019","unstructured":"Teng T, Li Q, Liu Z, Li X, Liu Z, Liu H, Liu F, Xie L, Wang H, Zhang L, et al. Characterization and genome analysis of novel Klebsiella phage Henu1 with lytic activity against clinical strains of Klebsiella pneumoniae. Adv Virol. 2019;164(9):2389\u201393.","journal-title":"Adv Virol"},{"issue":"12","key":"567_CR61","first-page":"2799","volume":"165","author":"M Li","year":"2020","unstructured":"Li M, Xiao Y, Li P, Wang Z, Qi W, Qi Z, Chen L, Du H, Zhang W. Characterization and genome analysis of Klebsiella phage P509, with lytic activity against clinical carbapenem-resistant Klebsiella pneumoniae of the KL64 capsular type. Adv Virol. 2020;165(12):2799\u2013806.","journal-title":"Adv Virol"},{"key":"567_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02788-9","author":"MM D\u2019Andrea","year":"2017","unstructured":"D\u2019Andrea MM, Marmo P, De Henrici Angelis L, Palmieri M, Ciacci N, Di Lallo G, Dematt\u00e8 E, Vannuccini E, Lupetti P, Rossolini GM, et al. \u03c6bO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic clonal group 258 clade II lineage. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-02788-9.","journal-title":"Sci Rep"},{"issue":"3","key":"567_CR63","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12223-011-0039-8","volume":"56","author":"E Jo\u0144czyk","year":"2011","unstructured":"Jo\u0144czyk E, K\u0142ak M, Mi\u0119dzybrodzki R, G\u00f3rski A. The influence of external factors on bacteriophages\u2014review. Folia Microbiol. 2011;56(3):191\u2013200.","journal-title":"Folia Microbiol"},{"issue":"1","key":"567_CR64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s42003-022-03001-y","volume":"5","author":"Q Fang","year":"2022","unstructured":"Fang Q, Feng Y, McNally A, Zong Z. Characterization of phage resistance and phages capable of intestinal decolonization of carbapenem-resistant Klebsiella pneumoniae in mice. Commun Biol. 2022;5(1):48.","journal-title":"Commun Biol"},{"issue":"8","key":"567_CR65","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s00203-022-03143-x","volume":"204","author":"NF Michodigni","year":"2022","unstructured":"Michodigni NF, Nyachieo A, Akhwale JK, Magoma G. Kimang\u2019a AN: Genomic evaluation of novel Kenyan virulent phage isolates infecting carbapenemase-producing Klebsiella pneumoniae and safety determination of their lysates in Balb\/c mice. Arch Microbiol. 2022;204(8):532.","journal-title":"Arch Microbiol"},{"key":"567_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-020-01485-w","author":"F Zurabov","year":"2021","unstructured":"Zurabov F, Zhilenkov E. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation. Virol J. 2021. https:\/\/doi.org\/10.1186\/s12985-020-01485-w.","journal-title":"Virol J"},{"key":"567_CR67","doi-asserted-by":"publisher","DOI":"10.1128\/MRA.00024-20","author":"TL Thurgood","year":"2020","unstructured":"Thurgood TL, Sharma R, Call JJ, Chronis JD, Dawson DD, Finnegan ZK, Foster KW, Meek T, Potts E, Sirrine MR, et al. Genome sequences of 12 phages that infect Klebsiella pneumoniae. Microbiol Resour Announc. 2020. https:\/\/doi.org\/10.1128\/MRA.00024-20.","journal-title":"Microbiol Resour Announc"},{"issue":"9","key":"567_CR68","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/cid\/ciz782","volume":"70","author":"M Corbellino","year":"2020","unstructured":"Corbellino M, Kieffer N, Kutateladze M, Balarjishvili N, Leshkasheli L, Askilashvili L, Tsertsvadze G, Rimoldi SG, Nizharadze D, Hoyle N, et al. Eradication of a multidrug-resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation. Clin Infect Dis. 2020;70(9):1998\u20132001.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"567_CR69","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/microorganisms8040542","volume":"8","author":"Q Peng","year":"2020","unstructured":"Peng Q, Fang M, Liu X, Zhang C, Liu Y, Yuan Y. Isolation and characterization of a novel phage for controlling multidrug-resistant Klebsiella pneumoniae. Microorganisms. 2020;8(4):542.","journal-title":"Microorganisms"},{"issue":"4","key":"567_CR70","doi-asserted-by":"publisher","first-page":"e18597","DOI":"10.1371\/journal.pone.0018597","volume":"6","author":"A Cornelissen","year":"2011","unstructured":"Cornelissen A, Ceyssens PJ, T\u2019Syen J, Van Praet H, Noben JP, Shaburova OV, Krylov VN, Volckaert G, Lavigne R. The T7-related Pseudomonas putida phage \u03c615 displays virion-associated biofilm degradation properties. PLoS ONE. 2011;6(4):e18597.","journal-title":"PLoS ONE"},{"issue":"1","key":"567_CR71","doi-asserted-by":"publisher","first-page":"e0102321","DOI":"10.1128\/Spectrum.01023-21","volume":"9","author":"RA Dunstan","year":"2021","unstructured":"Dunstan RA, Bamert RS, Belousoff MJ, Short FL, Barlow CK, Pickard DJ, Wilksch JJ, Schittenhelm RB, Strugnell RA, Dougan G, et al. Mechanistic insights into the capsule-targeting depolymerase from a Klebsiella pneumoniae bacteriophage. Microbiol Spectr. 2021;9(1):e0102321.","journal-title":"Microbiol Spectr"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00567-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00567-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00567-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T12:04:00Z","timestamp":1677240240000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00567-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00567-1","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"16 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project followed the ethical principal and the national norms and standards for conducting medical research in Iran with approval ID: IR.KAUMS.MEDNT.REC.1400.023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}